Clinical significance of germline telomere length and associated genetic factors in patients with neuroblastoma

被引:0
|
作者
Bae, Joon Seol [1 ]
Lee, Ji Won [2 ]
Joung, Je-Gun [3 ]
Cho, Hee Won [2 ]
Ju, Hee Young [2 ]
Yoo, Keon Hee [2 ]
Koo, Hong Hoe [2 ]
Sung, Ki Woong [2 ]
机构
[1] Samsung Med Ctr, Res Inst Future Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Pediat, Samsung Med Ctr, 81 Irwon Ro, Seoul 135710, South Korea
[3] Cha Univ, Cha Bundang Med Ctr, Dept Biomed Sci, Seongnam, South Korea
基金
新加坡国家研究基金会;
关键词
CELL-ADHESION MOLECULE; LUNG-CANCER RISK; BLOOD; EXPRESSION; DNA;
D O I
10.1038/s41598-022-17246-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Studies investigating the relationship between germline telomere length and the clinical characteristics of tumors are very limited. This study evaluated the relationship between germline telomere length and the clinical characteristics of neuroblastoma. In addition, a genome-wide association study (GWAS) was performed to investigate the genetic factors associated with germline telomere length. The germline telomere length of peripheral blood mononuclear cells from 186 patients with neuroblastoma was measured by quantitative polymerase chain reaction. The association between germline telomere length and clinical characteristics, including long-term survival, was investigated. For the GWAS, genotyping was performed with a high-density bead chip (Illumina, San Diego, CA, USA). After strict quality-control checks of the samples, an association analysis was conducted. The result showed that longer germline telomeres were significantly associated with longer event-free survival (P = 0.032). To identify significantly assocated genetic markers for germline telomere length, genome wide association analysis was performed. As a result, several single nucleotide polymorphisms located in HIVEP3, LRRTM4, ADGRV1, RAB30, and CHRNA4 genes were discovered. During gene-based analysis (VEGAS2 tool), the CNTN4 gene had the most significant association with germline telomere length (P = 1.0E-06). During gene ontology analysis, susceptible genes associated with germline telomere length were mainly distributed in neurite morphogenesis and neuron development. A longer germline telomere length is associated with favorable prognostic factors at diagnosis and eventually better event-free survival in patients with neuroblastoma. In addition, the GWAS demonstrated that genetic markers and genes related to germline telomere length are associated with neurite morphogenesis and neuron development. Further research with larger cohorts of patients and functional investigations are needed.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Clinical significance of germline telomere length and associated genetic factors in patients with neuroblastoma
    Joon Seol Bae
    Ji Won Lee
    Je-Gun Joung
    Hee Won Cho
    Hee Young Ju
    Keon Hee Yoo
    Hong Hoe Koo
    Ki Woong Sung
    [J]. Scientific Reports, 12
  • [2] Clinical Significance of Telomere Length and Associated Proteins in Oral Cancer
    Sainger, Rachana N.
    Telang, Shaila D.
    Shukla, Shilin N.
    Patel, Prabhudas S.
    [J]. BIOMARKER INSIGHTS, 2007, 2 : 9 - 19
  • [3] Genetic and clinical determinants of telomere length
    Allaire, Patrick
    He, Jing
    Mayer, John
    Moat, Luke
    Gerstenberger, Peter
    Wilhorn, Reynor
    Strutz, Sierra
    Kim, David S. L.
    Zeng, Chenjie
    Cox, Nancy
    Shay, Jerry W.
    Denny, Joshua
    Bastarache, Lisa
    Hebbring, Scott
    [J]. HUMAN GENETICS AND GENOMICS ADVANCES, 2023, 4 (03):
  • [4] Common genetic variants associated with telomere length confer risk for neuroblastoma and other childhood cancers
    Walsh, Kyle M.
    Whitehead, Todd P.
    de Smith, Adam J.
    Smirnov, Ivan V.
    Park, Minsun
    Endicott, Alyson A.
    Francis, Stephen S.
    Codd, Veryan
    Samani, Nilesh J.
    Metayer, Catherine
    Wiemels, Joseph L.
    [J]. CARCINOGENESIS, 2016, 37 (06) : 576 - 582
  • [5] Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma
    Jang, Jeong-Won
    Kim, Jin-Seoub
    Kim, Hye-Seon
    Tak, Kwon-Yong
    Lee, Soon-Kyu
    Nam, Hee-Chul
    Sung, Pil-Soo
    Kim, Chang-Min
    Park, Jin-Young
    Bae, Si-Hyun
    Choi, Jong-Young
    Yoon, Seung-Kew
    [J]. CANCERS, 2021, 13 (09)
  • [6] Significance of TERT genetic alterations and telomere length in hepatocellular carcinoma
    Kim, Jin Seoub
    Kim, Hye Seon
    Lee, Soon Kyu
    Nam, Hee Chul
    Sung, Pil Soo
    Kim, Chang Min
    Park, Jin Young
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Jang, Jeong Won
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S488 - S489
  • [7] Factors associated with recurrence and survival length following relapse in patients with neuroblastoma
    Basta, Nermine O.
    Halliday, Gail C.
    Makin, Guy
    Birch, Jillian
    Feltbower, Richard
    Bown, Nick
    Elliott, Martin
    Moreno, Lucas
    Barone, Giuseppe
    Pearson, Andrew D. J.
    James, Peter W.
    Tweddle, Deborah A.
    McNally, Richard J. Q.
    [J]. BRITISH JOURNAL OF CANCER, 2016, 115 (09) : 1048 - 1057
  • [8] Factors associated with recurrence and survival length following relapse in patients with neuroblastoma
    Nermine O Basta
    Gail C Halliday
    Guy Makin
    Jillian Birch
    Richard Feltbower
    Nick Bown
    Martin Elliott
    Lucas Moreno
    Giuseppe Barone
    Andrew DJ Pearson
    Peter W James
    Deborah A Tweddle
    Richard JQ McNally
    [J]. British Journal of Cancer, 2016, 115 : 1048 - 1057
  • [9] Genetic, parental and lifestyle factors influence telomere length
    Andreu-Sanchez, Sergio
    Aubert, Geraldine
    Ripoll-Cladellas, Aida
    Henkelman, Sandra
    Zhernakova, Daria, V
    Sinha, Trishla
    Kurilshikov, Alexander
    Cenit, Maria Carmen
    Bonder, Marc Jan
    Franke, Lude
    Wijmenga, Cisca
    Fu, Jingyuan
    van der Wijst, Monique G. P.
    Mele, Marta
    Lansdorp, Peter
    Zhernakova, Alexandra
    [J]. COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [10] NEUROBLASTOMA - CLINICAL-SIGNIFICANCE OF GENETIC ABNORMALITIES
    BRODEUR, GM
    [J]. CANCER SURVEYS, 1990, 9 (04) : 673 - 688